Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins

Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins

US Patent 10253070 · Granted Apr 9, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2022
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2022
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2021
Specific murine and humanized monoclonal antibodies detecting pathology associat2020
Specific murine and humanized monoclonal antibodies detecting pathology associat2020
Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal 2020
Preventing and treating amyloid-beta deposition by stimulation of innate immunit2019
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2018
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, n2018
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2017
Immunotherapy targeting of the shared abnormal conformational state of amyloidog2017
Method for treating amyloid disease2017